FCMI
Foresite Capital Management I Portfolio holdings
AUM
$21.4M
This Quarter Return
+38.74%
1 Year Return
-80.48%
3 Year Return
-40.72%
5 Year Return
–
10 Year Return
–
AUM
$355M
AUM Growth
+$355M
(+12%)
Cap. Flow
-$85M
Cap. Flow
% of AUM
-23.94%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
Novavax
NVAX
|
$7.24M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$1.25M |
Top Sells
| 1 |
10x Genomics
TXG
|
$93.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
10x Genomics
TXG
$1.74B
| $343M | 96.54% | 2,750,000 -750,000 | -21% | -$93.5M |
|
|
2
Novavax
NVAX
$1.21B
| $7.24M | 2.04% | +66,810 | New | +$7.24M |
|
|
EPZM
3
DELISTED
Epizyme, Inc
EPZM
| $2.91M | 0.82% | 243,759 | – | – |
|
|
XLRN
4
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.15M | 0.61% | 19,100 +11,100 | +139% | +$1.25M |
|